Reducing in Medical Technology

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

... of golimumab may benefit these patients by reducing the signs and symptoms of rheumatoid arthritis." ... with methotrexate (MTX), is indicated for reducing the signs and symptoms in adult patients with moderately to severely active RA; reducing signs and symptoms in adult patients with ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... with methotrexate (MTX), is indicated for reducing the signs and symptoms in adult patients with moderately to severely active RA; reducing signs and symptoms in adult patients with ... active PsA, alone or in combination with MTX; and reducing signs and symptoms in adult patients with active ...

New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform

... that prevention and wellness efforts are a key to reducing costs within a reformed health care system. And ... can result in a big payoff in a short time -- reducing health care costs, increasing the productivity of ... that Americans see the value of prevention for reducing disease, improving quality of life, and lowering ...

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... for the following indications: reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. reducing signs and symptoms in patients with active AS. reducing signs and symptoms and inducing and maintaining ...

Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

... objective of REDUCE-1 was to evaluate HZT-501 in reducing the proportion of patients who develop ... objective of REDUCE-2 was to evaluate HZT-501 in reducing the proportion of patients who develop ... during the peak time of ulceration risk, thus reducing the risk of NSAID-induced ulcers. About ...

ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting

... demonstrated Bepreve 1.5% was effective at reducing ocular itching for at least 8 hours after dosing, ... dosed in both eyes was clinically effective in reducing ocular itching associated with allergic ... dosing and statistically superior to placebo in reducing ocular itching at CAC tests conducted 15 minutes, ...

New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy

... are considered for treatment guidelines for reducing cardiovascular risk," said American Heart ... ways to make the most positive impact possible in reducing heart disease and stroke." Spatz, who was ... "Clearly, as a nation, we are not adequately reducing the risk of those who, even under current ...

Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery

... demonstrated significant long-term benefit in reducing the risk of disease-free survival events by 12% (P=0.03, HR=0.88, 95% CI: 0.78-0.99) and reducing the risk of distant metastases by 15% (P=0.05, ... in improving disease-free survival and reducing the risk of recurrence, the tamoxifen-only ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

... highlight observations and interventions aimed at reducing complications and mortality from sickle cell ... treatments, has been highly successful in reducing the rate of primary stroke in children with the ... used for preventing painful sickle cell crises, reducing the frequency and length of hospital stays, and ...

Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

... objective of REDUCE-1 was to evaluate HZT-501 in reducing the proportion of patients who ... objective of REDUCE-2 was to evaluate HZT-501 in reducing the proportion of patients who develop ... the peak time of ulceration risk, thus reducing the risk of NSAID-induced ulcers. HZT-501 has ...

Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD

... with MP-376 for use as a maintenance therapy in reducing the incidence of pulmonary exacerbations in ... in lung function, improving quality of life, and reducing hospitalizations. We believe aerosol MP-376 ... administration of MP-376 is used, potentially reducing the incidence of systemic side effects. MP-376 is ...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... is approved for the following indications: -- reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- reducing signs and symptoms in patients with active AS. -- reducing signs and symptoms and inducing and maintaining ...

Bionovo's MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes

... in the Phase 2 trial for the primary endpoint of reducing the number of hot flashes when compared to ... of MF101 were more effective than placebo at reducing the frequency and severity of hot flashes from ... the higher dose of MF101 was more effective at reducing night time awakenings from hot flashes compared ...

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

... Micardis(R) (telmisartan) against placebo in reducing the composite endpoint of cardiovascular death, ... was as effective as the ACE inhibitor ramipril in reducing the risk of cardio- and cerebrovascular events, ... (10) Levenson J. et al. reducing the global burden of cardiovascular disease: the ...

Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R)

... Significant but Show Favorable Trend in reducing Most CV Events ... had a statistically significant effect on reducing major CV events associated with diabetes. However, it was found that there was a favorable trend in reducing all CV events, except CV death, among the ...

Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission

... Development, Abbott. HUMIRA is indicated for reducing signs and symptoms and inducing and maintaining ... to conventional therapy. HUMIRA is indicated for reducing signs and symptoms and inducing clinical ... disease, HUMIRA is also approved by the FDA for reducing signs and symptoms, inducing major clinical ...

Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents

... in biodegradable polymers, are effective in reducing neointimal proliferation in comparison with bare ... (Supralimus) stents are effective in reducing neointimal proliferation and the risk of repeat ... drugs (Paclitaxel & Sirolimus) were effective in reducing restenosis on the same vehicle and platform. So ...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

... is approved for the following indications: -- reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- reducing signs and symptoms in patients with active AS. -- reducing signs and symptoms and inducing and maintaining ...

U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older

... (FDA) has approved ORENCIA(R) (abatacept) for reducing signs and symptoms in pediatric patients six ... indication statement is: ORENCIA is indicated for reducing signs and symptoms, inducing major ... . About ORENCIA ORENCIA is indicated for reducing signs and symptoms, inducing major clinical ...

American Heart Association Journal Report: Reducing Kids' Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks

... 250 kcal per week," Dr. He said. "Not only would reducing salt intake lower blood pressure in children, but ... already added to food by the food industry. reducing salt would not necessarily impact food taste, she ... in physical activity, "could go a long way in reducing the present scourge of cardiovascular disease in ...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

... is approved for the following indications: -- reducing signs and symptoms, inhibiting the progression of ... in combination with methotrexate. -- reducing signs and symptoms in patients with active AS. -- reducing signs and symptoms and inducing and maintaining ...

Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis

... psoriasis, HUMIRA is approved by the FDA for reducing signs and symptoms, inducing major clinical ... to severely active RA. HUMIRA is indicated for reducing the signs and symptoms of active arthritis, ... ulcerative colitis. HUMIRA is also approved for reducing signs and symptoms in patients with active AS. ...

Measles Deaths in Africa Plunge by 91%

... vaccination campaigns have had a major impact on reducing global measles deaths. From 2000 to 2006, an ... A key factor contributing to progress in reducing measles deaths has been the strong support of the ... Measles Initiative is a partnership committed to reducing measles deaths globally. Launched in 2001, the ...

Congressional Funds Awarded for Testing of Antimicrobial Copper Metals

... Study of Copper as Effective Means of reducing Hospital-Acquired Infections and Improving Indoor ... and air-conditioning (HVAC) systems in reducing the incidence of harmful microbes that spread ... the effectiveness of copper surfaces in reducing the colonization of HVAC systems by harmful ...

VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome

... (FDG-PET) to measure the impact of VIA-2291 on reducing vascular inflammation in treated patients. The ... for measuring the effect of VIA-2291 on reducing vascular inflammation in atherosclerosis." Larry ... that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is ...

Abbott's m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award

... by the Food and Drug Administration (FDA) for reducing signs and symptoms, inducing major clinical ... rheumatoid arthritis. HUMIRA is indicated for reducing the signs and symptoms of active arthritis, ... drugs (DMARDs). HUMIRA is also approved for reducing signs and symptoms in patients with active ...

Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help

... cells from dying, and showed improvements in reducing compounds that lead to lesions in the brains of ... flavonoids may improve cardiovascular health by reducing inflammation and improving blood vessel ... rich in catechins may aid in weight management by reducing body fat and in particular visceral fat, possibly ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

... Tamoxifen is one of the oldest and most widely used treatments for reducing the risk of breast cancer recurrence among women with estrogen-dependent ... With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 ...

New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring

... Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ... Masimo, SET, Signal Extraction Technology, Improving Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ...

Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

... data on a number of other promising new targets demonstrating that reducing levels of these targets with antisense drugs can significantly lower blood ... showing antisense drugs reduced fat mass and body weight in animals by reducing levels of targets in peripheral tissues such as liver and fat without ...

Two New Clinical Studies Show That Limited Exposure to Blood Transfusion Significantly Increases Morbidity and Mortality After Surgery

... Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ... Masimo, SET, Signal Extraction Technology, Improving Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ...

vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

... the SECRITT I trial as a significant step toward achieving its mission of reducing deaths from heart attacks. According to Prescient CEO Patricia Scheller, ... Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the ....

New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease

... Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ... Masimo, SET, Signal Extraction Technology, Improving Outcomes and reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... to severely active rheumatoid arthritis. Cimzia(R) is also approved for reducing signs and symptoms of Crohn's disease and maintaining clinical response in ... The U.S. Food and Drug Administration (FDA) has approved Cimzia (R) for reducing signs and symptoms of Crohn's disease and maintaining clinical response in ...

Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure

... immunodeficiency virus (HIV) and the risk of coital injury -- without reducing pleasure or causing sexual dysfunction. The first study, by ... removes the skin surface which is most susceptible to HIV infection, reducing not eliminating the risk of contracting HIV. No differences were found in ...

Oh, My Aching Back: Give Me a Shot of Ozone

... into a herniated disk. The treatment can limit pain and inflammation by reducing the disk's volume. Currently, open diskectomy and microdiskectomy (both ... discovered that a simple incompressible fluid model predicted that reducing disk volume by 0.6 percent results in an intradiscal pressure reduction of ...

AndroScience Corporation Announces Phase 2a Study Results on ASC-J9(TM) for the Treatment of Acne

... preliminary efficacy. ASC-J9(TM) demonstrated a clinical benefit in reducing inflammatory lesions compared to placebo at certain dosages and at ... act on a key cause of acne, the androgen activation system, through reducing high levels of androgen receptor present in the sebaceous gland to lower ...

Experience Not Always the Best Prescription for Snowblowers

... safety features may be just what the doctor ordered when it comes to reducing snowblower-related hand injuries, it adds. "Snowblower injuries are ... concludes that additional safety features for snowblowers would aid in reducing hand injuries ( http://orthoinfo.aaos.org/topic.cfm?topic=A00014 ), and ...

IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile

... improving the durability of orthopedic repairs, decreasing pain, reducing scarring and reducing the risk of infection." About Hospital del Trabajadar Hospital ...

New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation

... stroke and congestive heart failure. In addition to preventing stroke and reducing the burden of the disease, successful management of AF should also aim at further reducing cardiovascular morbidity and mortality. The goals of treatment for ...